- ►epgasia.com [PDF] - Free from Publisher BW Bode, P Strange - Diabetes Care, 2001 - Am Diabetes Assoc OBJECTIVE— The purpose of this study was to compare the efficacy, safety, and
pump compatibility of insulin aspart (a rapid-acting insulin analog) and
buffered regular human insulin in patients with type 1 diabetes undergoing ... Cited by 83 - Related articles - BL Direct - All 13 versions
- ►diabetesjournals.org B Bode, R Weinstein, D Bell, J McGill, D … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—Treatment groups had similar baseline HbA 1c (7.3% ±0.7 for IAsp,
7.5% ±0.8 for BR, and 7.3% ±0.7 for lispro). After 16 weeks of treatment, HbA
1c values were relatively unchanged from baseline, and the mean changes in ... Cited by 122 - Related articles - BL Direct - All 20 versions
- Free from Publisher R Renner, A Pfutzner, M Trautmann, O Harzer, … - Diabetes care, 1999 - Am Diabetes Assoc C ontinuous subcutaneous insulin infu- sion (CSII) with insulin pump devices is,
to date, the besttherapeuticoption to achieve near- no rmal blood glucose con- t
rol. Inpart icular, distinct subgroups of dia- betic patients may ... Cited by 149 - Related articles - BL Direct - All 6 versions
S Schmau, A König, R Landgraf - Diabetic Med, 1998 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 44 - Related articles - BL Direct - All 4 versions
- Free from Publisher V Melki, E Renard, V Lassmann-Vague, S Boivin … - Diabetes care, 1998 - Am Diabetes Assoc T he Diabetes ControlandComplications Trial(DCCT) has clearlydemonstrated that
intensive diabetes management with the goal of maintaining near eugly- cemia
couldreduce the risk ofdevelopment and pro g ressionof ... Cited by 150 - Related articles - BL Direct - All 6 versions
P Raskin, JH Holcombe, WV Tamborlane, JI … - Journal of diabetes and its complications, 2001 - Elsevier This study compared glycemic control achieved with insulin lispro or buffered
regular human insulin in patients with Type 1 diabetes treated with continuous
subcutaneous insulin infusion (CSII) using an external insulin pump. In ... Cited by 65 - Related articles - BL Direct - All 11 versions
- Free from Publisher P Raskin, RA Guthrie, L Leiter, A Riis, L … - Diabetes Care, 2000 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS — This was a randomized open-label parallel-group
study conducted at 59 centers in the US and Canada. Sub- jects with type 1
diabetes were treated with IAsp or HI as part of an intensive insulin reg- ... Cited by 196 - Related articles - BL Direct - All 7 versions
B Zinman, H Tildesley, JL Chiasson, E Tsui, T … - Diabetes, 1997 - Am Diabetes Assoc Insulin lispro is a human insulin analog that dissociates more rapidly than
human regular insulin after subcutaneous injection, resulting in higher insulin
levels at an earlier point in time and a shorter duration of action. The ... Cited by 267 - Related articles - BL Direct - All 5 versions
PD Home, A Lindholm, A Riis - Diabetic Medicine, 2000 - ingentaconnect.com Methods Prospective, multi-centre, randomized, open-labelled, parallel-group
trial lasting 6 months in 88 centres in eight European countries and including
1070 adult subjects with Type 1 diabetes. Study patients were randomized ... Cited by 117 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org [PDF] PD Home, A Lindholm, B Hylleberg, P Round - Diabetes Care, 1998 - Am Diabetes Assoc F rom the Human Diabetes and Metabolism Research Centre (PDH), University of
Newcastle upon Ty ne , UK; and Novo Nordisk A/S, Bagsvaerd, Denmark. A dd ress
correspondence and reprint requests to Prof. PD Home, Department of ... Cited by 170 - Related articles - BL Direct - All 6 versions
